Parathyroid hormone analogues substituted at AA 25, 26, 27, and

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

530324, 530399, 930 10, 930DIG820, 930DIG821, A61K 3736, C07K 710

Patent

active

053170105

ABSTRACT:
Analogues of bovine and human parathyroid hormone, wherein twenty-fifth, twenty-six and twenty-seventh positions of the natural hormone, Arg-Lys-Lys- each have been substituted with Ala, Asn, Asp, Cys, Gln, Glu, Gly, His, Ile, Leu, Met, Phe, Pro, Ser, Thr, Trp, Tyr or Val have been found to retain bone cell effect with minimal effects on blood pressure and smooth muscle, including cardiac muscle. It has further been found that this effect can be obtained by using a synthetic PTH containing only the first 34 amino acids of PTH, with substitution at the twenty-fifth, twenty-sixth and twenty-seventh amino acids as described. These analogues of PTH also are effective in the treatment of osteoporosis and other bone diseases.

REFERENCES:
patent: 4086196 (1978-04-01), Tregear
patent: 4771124 (1988-09-01), Rosenblatt
patent: 4833125 (1989-05-01), Neer

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Parathyroid hormone analogues substituted at AA 25, 26, 27, and does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Parathyroid hormone analogues substituted at AA 25, 26, 27, and , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Parathyroid hormone analogues substituted at AA 25, 26, 27, and will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1628197

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.